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One of the principal problems of modern ob-
stetrics is that of estimating fetal maturity,
mainly in those conditions of obstetrical pathology
in which the therapeutic Interruption of preg-
nancy is indicated.
The classical concept, according to which a
fetus is considered to be mature1 when it has
reached the gestational age of 36 weeks, is still
valid.
The need f or having at one's disposal parameters
which are not äs uncertain äs the classical criteria
(amenorrhoea, onset of Symptoms of pregnancy,
uterine development, fetal movements), has
directed modern research towards the devel-
opment of instrumental and laboratory techniques
capable of furnishing somatic, biochemical, and
cytological indices, which nowadays constitute
the basic criteria for estimating gestational age
and, from this, fetal maturity.
Fundamentally, these methods comprise: ultra-
sonic echography, which furnishes fetal somatic
parameters, particularly the dimensions of the
biparietal diameter (B. D.), and the biochemical,
cytological, and hormonal investigation of the
amniotic fluid.
The validity of ultrasonic echography, and the
biological and clinical significance of the bio-
chemical, cytological, and hormonal findings in
the amniotic fluid, have been the subject of a
vast body of literature [l, 2, 3, 4, 6, 7, 8, 9, 10, 11,
13, 14, 16, 17, 18, 19, 20, 21, 23, 28, 29, 30, 33,
34, 35, 39, 41, 42, 43, 44, 45, 46, 48, 49].
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The most recent studies [5, 12, 15, 22, 24, 25, 26,
27, 31, 32, 36, 37, 38, 47] have demonstrated the
value of analysis of phospholipid constituents äs
a specific method for estimating the degree of
maturation of the fetal lung; the validity of this
method has now been confirmed by numerous
clinical observations, which show beyond doubt
haw neonatal prognosis, äs far äs the development
of the respiratory syndrome is concerned, is
closely related to the lecithin content of the
amniotic fluid.
Preliminary results of investigations by some
authors [22, 32] have, moreover, produced
evidenee that, particulary in some forms of high
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risk pregnancy, there is no parallelism, between which are regarded äs an expression of maturity
the stage of pulmonary maturation and that of have been established äs 8.7 cm for the B. D.;
somatic and gestational maturation, and that the 10% for the number of, orange-stained cells; 0
maturity of the lungs seems to be very important for AÖD 450 nm; 1.8 mg% for creatinine;
for adaptation to extrauterine life. L/S r. ^ 2, or positive F. T. for determining
It was in order to contribute to the solution of pulmonary maturity. In the 135 cases in which
this problem that the present investigation was the analysis of pulmonary maturity was carried
undertaken: By comparing the most important out by both methods, only the result of L/S r.
methods in present day use for estimating was taken into consideration.
gestational age and, thus, indirectly, somatic, Finally, each parameter investigated was corre-
organic, biochemical and functional fetal de- lated with the degree of neoüatal respiratory
velopment, with the prognostic value of the distress syndrome (RDS) and mortality.
methods for estimating pulmonary maturity.
The purpose is to give clinical obstetricians the
possibility of arriving at a diagnostic and prog- 2' Results and discusslon
nostic assessment and a relatively effective therapy Figure l represents the distribution of fetal B. D.
using the most effective methods. values in relation to gestational age.
It can be seen that there is no perfect correspon-
dence: in fact, there are 13.7% false positive
l Material and methods
 results («fake positive» = B. D> 8Jcm or
The investigation was carried out in a total of more in pregnancies of less than 36 weeks); and
369 patients with normal pregnancy or pregnancy 5.1% false negative results (B. D. values less
complicated by maternal or fetal pathology, than 8.7 cm in pregnancies of 36 weeks and more)
between 17 and 42 week of gestation. the total öf false results heilig 9.3%.
The group of pathological cases is represented by Furthermore in diabetes there is evidence for
26 cases of diabetes (A, B and C according to precocious somatic development äs compared
WHITE'S classification), 39 cases of toxemia and with the mean, shown particulary by the absence
5 cases of fetal anencephaly. of false negative results.
The investigations consisted of measuring the Figure 2 shows the distribution of the amniotic
fetal biparietal diameter (B. D.) by ultrasonic fluid creatinine content in mg% in relation to
echography, and of the following cytological gestational age.
and biochemical examinations of the amniotic It can be seen that also for creatinine there is no
fluid, obtained in each case within 48 hours perfect correspondence; the percentage of false
preceding delivery, by transabdominal or trans- positives (i. e. 1.8 or more- prior to the 36th
vaginal amniocentesis: 1. a percentage calculation week) is 13.7%, and of false negatives (values
of orange-stained cells; 2. determination of below 1.8 from week 36 onwards) 14.6%, the
ZlOD 450 nm for bilirubin; 3. creatinine level; total percentage being 14.2%.
4. determination of pulmonary surfactant, which Thus, the margin of error in this method exceeds
was carried out in 199 cases by determining the that of the preceding one, especially äs far äs
lecithin/sphingomyelin ratio (L/S r.) with GLUCK'S false negative results are concerned.
Chromatographie technique, in 37 cases by the Figure 3 represents the distribution of percentage
semiquarititative assay with CLEMENT'S foam values of orange-stained cells in the amniotic
test (F. T.), and in 135 cases by both methods. fluid in relation to gestational age.
These parameters were correlated with the With this method, the incidence of false positives
estimated week of pregnancy. is hardly 1.3%, of false negatives 27.6%, the
In agreement with literary data, the calculated total incidence of false results being 20.5%.
36th week of gestation was conventionally taken It can be seen that with this method the margin
äs an expression of gestational maturity; the of error is still larger, but almost exclusively for
corresponding values of the parameters examined the false negatives; positivity of this index, on the
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Fig. 1. Biparietal Diameter (cm) correlated with weeks of gestation.
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Fig. 2. Creatinine levels (mg per cent) in amniotic fluid correlated with weeks of gestation.
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Fig. 3. Fat cells (%) in amniotic fluid correlated with weeks of gestation.
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Fig. 4. Bilirubin content in amniotic fluid (4OD 450 μπι) correlated with weeks of gestation.
other band, shows a remarkable agreement with The incidence of false positives is 17.7%, of
the stage of gestational maturity. false negatives 25.1%, total 22.3%.
Figure 4 presents the distribution of values of Thus the method is the least precise for estimating
ΑΟΌ 450 nm in the amniotic fluid in relation to gestational age since it has the highest margins of
gestational age. error both in the positive and the negative cases.
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Tab. I. Absolute and per cent incidence of falses, relative to each mcthod.
£8.7 cm
Biparietal Diameter
< 8.7 cm
=0
A ÖD 450 nm
>o
10%
Fat cells
<io%
Creatinine
<1.8mg%
L/S ratio ^2 or
Foam test positive
N.
168
174
113
175
76
199
131
150
168
False positive
< 36 wccks
23 (13.7%)
20 (17.7%)
1 (1.3%)
18 (13.7%)
24 (14.2%)
Falsc negative
^ 36 weeks
9 (5.1%)
44 (25.1%)
55 (27.6%)
22 (14.6%)
Total
32 (9.3%)
64 (22.3%)
56 (20.5%)
40 (14.2%)
L/S ratio <2 or
Foam test int. or neg.
38 (10.8%)
181 14 (7.7%)
Table I summarises the diagnostic value of the
methods mentioned above äs indices of gestational
maturity. It also contains the results of the
pulmonary maturity tests.
In classifying the results of the tests of pul-
monary maturity the following criterium was
used: the whole group was divided into two
subgroups of which the first one comprised
every case that presented L/S ratio ^ 2 and the
cases only evaluated by F. T. that presented
positive result; the second one comprises every
case that presented L/S ratio < 2 and the cases
only evaluated by F. T. that presented negative
or intermediate result.
The analysis of the results shows that, taken
absolutely, the best index for estimation is the
B. D., followed by the L/S tatio and the F. T.,
then by creatinine, the orange-stained cells, and
finally, by the ZlOD.
However, if only the margin of error for the
positive values, i. e. those values regarded äs
indices of gestational maturity, is taken into
consideration, it follows that the most correct
method is that of the orange-stained cells,
followed by the B. D., the creatinine, the pul-
monary maturity test, and the zJOD; vice versa,
for the negative values, the most exact method
is the B. D., followed by the pulmonary maturity
tests, creatinine, ZlOD, orange-stained cells.
Tab. II. Relationship between pulmonary maturity tests
and RDS and neonatal mortality due to RDS.
N RDS Mortality
L/S ratio ^  2 or
Foam test
positive 165
L/S ratio < 2 or
Foram test int.
or neg. 73
2 (1,2%)
23 (31.5%)
1 (0.6%)
16 (21.9%)
Taken absolutely, however, the echographic
measurement of the fetal B. D. seems to give the
most valid results when estimating gestational
maturity of the fetus.
Table II represents the results obtained by
correlating the two methods for determining
fetal pulmonary development and the behaviour
of the newborn with regard to the possible
development of the RDS and mortality.
The negligible incidence of RDS and mortality
in the group which has reached pulmonary
maturity, and the greater incidence in the not
yet mature group is evidence of the prognostic
value of these methods.
When these results are confronted with those
emerging from a comparison of other methods
for testing fetal maturity with neonatal behaviour
(RDS and mortality), (Tab. III) it is seen that
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Tab. . Gestational age and pulmonary maturity tests correlated with RDS and mortality due to RDS.
^8.7 cm
Biparietal diameter
< 8.7 cm
=0
ÖD 450 nm
>o
^10%
Fat cells
<io%
^1.8mg%
Creatinine
<1.8mg%
L/Sratio ^2 or
Foam test positive
L/S ratio <2 or
Foam test int. or neg.
N.
150
73
109
86
76
115
132
59
165
73
RDS
5 (3.3%)
19 (26%)
8 (7.3%)
15 (17.4%)
2 (2.6%)
22 (19.1%)
8 (6.1%)
16 (27.1%)
2 (1.2%)
23 (31.5%)
% of total
(2-6%)
(16.4%)
(5-5%)
(11.6%)
(1-3%)
(13%)
(3%)
(13.5%)
(0-6%)
(21-9%)
Mortality
•R
4
12
6
10
1
15
4
8
1
16
% of RDS
(80%)
(63.1%)
(75%)
(66.6%)
(50%)
(68.2%)
(50%)
(50%)
(50%)
(69.5%)
Tab. IV. Average gestational weck in which pulmonary
maturity is reached in normal and pathological pregnancies.
Average ± s. d.
Normal pregnancies
Diabetes
Toxemia
Rh isoimmunization
Premature membrane rupture
35.8±1
37.2±0.8
34.4±0.5
36.2±0.7
35.3±0.9
the best prognostic correspondence is found
for the pulmonary maturity tests rather than
for the tests of gestational maturity.
Table IV shows the average week of gestation
at which pulmonary maturity is reached in normal
cases and in some pathological pregnancies.
It can be seen how in normal cases about 36
weeks seems to correspond to gestational ma-
turity; on the other hand, in pathological cases
the time of fetal pulmonary maturation
deviates from what occurs in normal cases,
in some cases being earlier, in others later; this
would mean a divergence between gestational
and pulmonary maturity. This seems to be
particularly evident in the case of diabetes, in
which somatic maturation would be recorded äs
precocious [40] when compared with normal
cases, a fact which, in some way, is also shown
by the B. D. values.
On the other hand, the prognostic value of
pulmonary maturity tests, whose superiority to
gestational maturity tests has already been shown
in a complex analysis, is documented still more
clearly if the different groups of pathology are
analyzed.
Table V summarizes the results concerning the
group of pregnancies complicated by diabetes;
only the B. D. has been considered äs index of
gestational maturity, since it seems, äs has been
stated before, to be the method suited best for
such a purpose.
The divergence is evident between somatic
maturity (advanced) and«, pulmonary ma-
turity (retarded), which is documented by
8 cases with a B, D. ^ 8.7 cm and a L/S r. < 2;
this is reflected in the prognosis, in particular äs
far äs mortality is concerned. It is concluded that
pulmonary maturity, and its determination with
the aid of the tests is a definitely more valid index
for the purpose of a prognostic judgment.
3 Comment and conclusions
The conclusions which emerge the results
presented here seem to be important for guiding
the steps taken by the obstetrician.
Fetal maturity is a complex event, and must
therefore be evaluated by combined study of
the largest possible number of functions,
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Tab. V, B. D. and pulmonary maturity tests correlated with RDS incidence and mortality due to RDS in pregnancies
complicated by diabetes.
N. RDS Mortality
% of total N. % of RDS
B. D.
L/S ratio
B. D.
L/S ratio
B. D.
L/S ratio
B. D.
L/S ratio
^8.7 cm
^2
< 8.7 cm
^2
^8.7 cm
<2
< 8.7 cm
<2
11
0
8
6
2
(18.1%)
0
2
(25%)
5
(82.2%)
1
(9.9%) (50%)
0 0 0
2
(25%) (100%)
3
(50%) (60%)
with the aid of various methods, each of which
contributes in its own way. However, a clinical
evaluation of such methods shows how one
can assign to each of them a difFerent prognostic
and diagnostic value, so that it appears clear that
ultrasonic echographic measurement of the fetal
B. D. is, taken absolutely, the most suitable
method, and the one nearest to reality. Next to it,
creatinine assays seem to be very useful, whereas
the percentage of orange-stained cells and the
ZlOD appear to be subject to gross errors.
Such methods for evaluating gestational age
constitute a means for obtaining somewhat
indirect indices of the capacity of functional
autonomy, of adaption, and of survival of the
fetus whenever it is compelled to face the ex-
ternal environment prematurely.
The comparison of these methods with the pul-
monary maturity tests, demonstrate that the
latter make it possible to obtain higher safety
margins. This seems evident not only from the
complex analysis of the case material, but also
from a select analysis of individual groups of
high risk cases (Tab. V).
Moreover, a comparison of normal cases and
"high risk" cases shows that in certain patho-
logical conditions, in particular in diabetes and
toxemia, there is a deviation of the stage of
pulmonary maturation; it is advanced in toxemia
and retarded in diabetes. The whole matter
assumes great importance if the fact is called to
mind that in these circumstances fetal maturation,
äs determined by the ordinary tests for evaluating
the stage of gestation, seems to behave in a
reverse manner, äs is well demonstrated in the
case of diabetes.
The implications of all this for obstetric treatment
can easily be guessed.
When it becomes necessary to terminate ge-
station at a premature stage, one needs data
giving the most reliable prognosis for the new-
born survival.
Of major importance for this purpose is the
determination of the fetal B. D. äs an index of
somatic development and of the stage of ge-
Station, and the evaluation of fetal pulmonary
maturity. Moreover, it becomes evident that the
concept of gestational age by itself äs an index of
the moment of maturation of the fetus äs a
whole is uncertain in particular situations of
pathological pre^ciancy. It may be concluded,
that the highest degree of reliability should be
attributed to the tests for assessing pulmonary
maturity, which show a more perfect correlation
between the data provided by them and the fate
of the newborn.
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Summary
The validity of the assessment of the fetal age and pul-
monary maturity was evaluated on 369 patients at various
stages of normal pregnancy and complicated by diabetes,
toxemia and fetal anencephaly.
Gestational maturity was assessed by ultrasonic measure-
ment of the fetal biparietal diameter (Fig. 1) and by
analysing constituents of amniotic fluid (creatinine, bili-
rubin, fat cells) (Figs. 2—4) while pulmonary maturity
was assessed from the L/S ratio in the amniotic fluid.
Each individual method had a wide margin of error
(Tab. 7), however, ultrasound cephalometry gave the
best prediction for determination of fetal age.
In 135 selected cases lung maturity was assessed by using
two techniques, a thin layer Chromatographie determination
of the lecithin/sphingomyelin ratio in the amniotic fluid
and a rapid semiquantitative test to determine the titre of
surfactant which generates stable foam in presence of
ethanol. The results obtained 'by the two methods cor-
related well and were reliable in predicting the respiratory
distress syndrome. It appears that these methods make it
possible to obtain greater margins of reliability.
The role of fetal and maternal factors in the maturation of
fetal lungs was also studied in several pathological con-
ditions and it was noted that in many cases of maternal
diabetes mellitus lung maturity was reached at a
later age than in normal pregnancies (Tab. IV).
It is concluded that if termination of pregnancy is in-
dicated, the physician should rely more on the assess-
ment of lung maturity than on indicators of gestational
age.
Keywords: Bilirubin, creatinine, fat cells, fetal maturity, gestational age, high risk pregnancy, lecithin/sphingomyelin ratio,
pulmonal maturity, surfactant, ultrasonographic cephalometry.
Zusammenfassung
Bestimmung der fetalen Reife und der fetalen Lungen-
ventwicklung durch kombinierte Methoden
Bei 369 Patientinnen mit normalen und durch Diabetes
mellitus, Gestose sowie fetale Anenzephalie komplizierten
Schwangerschaften verschiedener Gestationsdauer wurde
die Zuverlässigkeit der Bestimmungsmethoden des fetalen
Alters und der Lungenreife überprüft. Die Reife nach
Gestationsdauer wurde durch die Messung des biparie-
talen Kopfdurchmessers (Fig. 1) und durch die Analyse
von Fruchtwasserbestandteilen (Kreatinin, Bilirubin, Fett-
Zellen) (Figs. 2—4) bestimmt, während die Lungenreife
durch den L/S-Quotienten im Fruchtwasser festgelegt
wurde. Jede einzelne Methode hatte eine große Fehler-
breite (Tab. I). Die Ultraschall-Kephalometrie jedoch
ergab die beste Voraussage bei-der fetalen Alters-
bestimmung.
Bei 135 ausgewählten Fällen wurden die Lungenreife mit
Hilfe von 2 Methoden bestimmt, einmal durch dünn-
schicht-chromatographische Bestimmung des Lecithin/
Sphingomyelin-Quotienten im Fruchtwasser und zum
anderen durch einen schnellen, semiquantitativen Test, bei
dem der Titer des surfactant bestimmt wird, der einen
stabilen Schaum in Gegenwart von Ätanol bildet. Die durch
die beiden Methoden erzielten Resultate korrelierten gut
miteinander und waren zuverlässig hinsichtlich der Voraus-
sage eines Atemnotsyndroms. Offenbar ermöglichen diese
Methoden eine Erweiterung des Vertrauensspielraumes.
Darüber hinaus wurde der Einfluß fetaler und mütterlicher
Faktoren auf die fetale Lungenreifung unter verschiedenen
pathologischen Bedingungen analysiert. Dabei konnte fest-
gestellt werden, daß in vielen Fällen eines mütterlichen
Diabetes mellitus die Lungenreife im Vergleich zu
normalen Schwangerschaften zu einem späteren Zeit-
punkt eintritt (Tab. IV).
Aus all diesem wird der Schluß gezogen, daß in den
Fällen, in denen eine Schwangerschaftsbeendigung
indiziert ist, der Arzt sich mehr auf die Bestimmung
der Lungenreife verlassen sollte und weniger auf die
Parameter der Gestationsdauer.
Schlüsselwörter: Bilirubin, fetale Reife, Fett-Zellen, Gestationsalter, Kephalometrie, Kreatinin, Lecithin/Sphingomyelin-
Quotient, pulmonale Reife, Risikoschwangerschaften, surfactant, Ultraschall.
Resume
Determination de la maturite foetale et du developpe-
ment des poumons dufoetus a l'aide de methodes com-
binees
On a etudie, en comparant plusieurs methodes, la validite
de Pestimation de Page foetal et de la maturite pulmonaire
sur 369 patientes representant differents stades de grossesse
soit normale, soit compliquee par diabete, toxemie et
anencephalie foetale. La maturite gestationnelle a ete
evaluee par le mesurage ultrasonographique du diametre
bi-parietal de la tete foetale (Fig. 1) et par Panalyse des
constituants du liquide amniotique (creatinine, bilirubine,
cellules oranges) (Figs. 2—4), tandis que la maturite
pulmonaire a ete evaluee par larecherche du „surfactant',
dans le liquide amniotique. Chaque methode prise en
particulier a demontre une marge d'erreur elevee
(Tab. I), bien que la cephalometrie ultrasonographique
ait donne les meilleures indications pour l'age foetal.
Dans les 135 cas selectionnes, Pevaluation du developpe-
ment pulmonaire a ete determinee par deux techniques:
Pune, la determination chrornatographique du rapport
lecithine/sphingomyeline, Pautre, un test semi-quantitatif
qui permet de determiner le titre de surfactant qui engendre
de Pecume stable en presence d'ethanol. II est tres facile de
confronter les resultats obtenus par les deux methodes,
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ces rosultats s'avorant tres utiles pour pradire le syndrome
de ddtresse respiratoire.
Les recherches sur la valeur diagnostique et prognostique
des tests de maturite pulmonaire semblent confirmer la
possibilito d'obtenir de plus grandes marges de s6curitd
gräce ä ces methodes.
Le role des facteurs maternels et foetaux dans la maturation
du poumon foetal a ote otudie aussi dans differentes con-
ditions pathologiques et on a remarque que dans plusierus
cas de diabete la maturito pulmonaire a ete atteinte ä
un äge plus tardif que dans les cas normaux (Tab. IV).
On a conclu que dans le traitement de ces cas, lorsque
Finterruption de la grossesse est indiquee, le modecin
doit compter davantage sur les rr^thodes d'evaluation
de la maturito pulmonaire que sur celles determinant
l'äge de gestation.
Mots-clos: äge de gestation, bilirubine, cellules oranges, cephalomotrie ultrasonographique, creatinine, grossesse ä
risque eleve, maturite foetale, maturite pulmonaire, rapport locithine/sphingomyeline, surfactant.
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